Literature DB >> 10357863

Isolate resistance of Blastocystis hominis to metronidazole.

K Haresh1, K Suresh, A Khairul Anus, S Saminathan.   

Abstract

Isolates of Blastocystis hominis from infected immigrant workers from Indonesia, Bangladesh and infected individuals from Singapore and Malaysia were assessed for growth pattern and degree of resistance to different concentrations of metronidazole. Viability of the cells was assessed using eosin-brillian cresyl blue which stained viable cells green and nonviable cells red. The Bangladeshi and Singaporean isolates were nonviable even at the lowest concentration of 0.01 mg/ml, whereas 40% of the initial inoculum of parasites from the Indonesian isolate at day one were still viable in cultures with 1.0 mg/ml metronidazole. The study shows that isolates of B. hominis of different geographical origin have different levels of resistance to metronidazole. The search for more effective drugs to eliminate th parasite appears inevitable, especially since surviving parasites from metronidazole cultures show greater ability to multiply in subcultures than controls.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357863     DOI: 10.1046/j.1365-3156.1999.00398.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  25 in total

1.  A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities.

Authors:  Haris Mirza; Joshua D W Teo; Jacqui Upcroft; Kevin S W Tan
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

2.  Development of metronidazole-resistant lines of Blastocystis sp.

Authors:  L A Dunn; K S W Tan; P Vanelle; T Juspin; M D Crozet; T Terme; P Upcroft; J A Upcroft
Journal:  Parasitol Res       Date:  2012-02-24       Impact factor: 2.289

3.  ME/CFS and Blastocystis spp or Dientamoeba fragilis, an in-house comparison.

Authors:  David Dunwell
Journal:  Br J Gen Pract       Date:  2013-02       Impact factor: 5.386

4.  Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies.

Authors:  Arutchelvan Rajamanikam; Suresh Kumar; Chandramathi Samudi; Madhav Kudva
Journal:  Parasitol Res       Date:  2018-06-05       Impact factor: 2.289

5.  Antiprotozoal potential of Salvadora persica against three virulent subtypes of Blastocystis sp.

Authors:  Mohammed A El-Bali; Abdulhafid Abdulhakim; Raafat T Mohamed; Mohamed A El-Malky; Rowaida A Bakri; Saeed A Al-Harthi
Journal:  J Parasit Dis       Date:  2020-07-27

6.  Epidemiological survey of Blastocystis hominis in Huainan City, Anhui Province, China.

Authors:  Ke-Xia Wang; Chao-Pin Li; Jian Wang; Yu-Bao Cui
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

Review 7.  New insights on classification, identification, and clinical relevance of Blastocystis spp.

Authors:  Kevin S W Tan
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 8.  Blastocystis, an unrecognized parasite: an overview of pathogenesis and diagnosis.

Authors:  Ivan Wawrzyniak; Philippe Poirier; Eric Viscogliosi; Meloni Dionigia; Catherine Texier; Frédéric Delbac; Hicham El Alaoui
Journal:  Ther Adv Infect Dis       Date:  2013-10

9.  Inhibitory effect of Ferula asafoetida L. (Umbelliferae) on Blastocystis sp. subtype 3 growth in vitro.

Authors:  Hala K El Deeb; Faisal M Al Khadrawy; Ayman K Abd El-Hameid
Journal:  Parasitol Res       Date:  2012-05-15       Impact factor: 2.289

10.  Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection.

Authors:  Kenneth F Boorom; Huw Smith; Laila Nimri; Eric Viscogliosi; Gregory Spanakos; Unaiza Parkar; Lan-Hua Li; Xiao-Nong Zhou; Ulgen Z Ok; Saovanee Leelayoova; Morris S Jones
Journal:  Parasit Vectors       Date:  2008-10-21       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.